Search
Contact us for the identity of Cardio-1 and for more information
The cardio device is a system based on the latest cardio research integrated with leading-edge AI technologies.

This device can detect a plethora of heart conditions with one test at the primary care stage, leading to a quick assessment and response to the patient’s condition. It provides clear, concise results for 22 ECG  findings, 14 echocardiogram findings, and over 20 more conditions that typically require more tests. This  is all done more accurately and quickly than what similar medical equipment can do today, and has been clinically validated.  

The revolutionary technology can detect cardiac conditions normally only diagnosed by a cardiologist using echocardiography.

How it works

  • Nurse captures bio-signals on the device
  • Uploaded to the Cloud
  • AI processes the signals
  • Report is sent to the doctor - same day
"From our fundamental research on heart bio-signals over the last 16 years, and the efforts of selected cardiology research teams in both Europe and North America, we have developed a unique evidence-based analysis algorithm and risk assessment system for physicians."  CEO Cardio-1. "We assist them to better determine cardiac status and establish a baseline for patient heart health." 

Heart Diseases Detected

Breakthrough cardiac diagnostics for the early detection of
Cardio-Vascular Disease [CVD],
Heart Failure [HF], and all
Heart Valves diseases [HVD].

Heart Disease -  a Global Problem


In the UK & Europe, the waiting time to see a cardio specialist can be up to one year [inefficient]. 

30% of women's hear attacks are missed by their family doctors [deadly].

A woman is 50% more likely than a man to receive the wrong initial diagnosis for a heart attack, per a study Bias & Biology [no excuse].
​​
​In one UK study, 70% of patients did not need to see a cardio specialist - [expensive].

Heart disease is the #1 cause of death in the Philippines [can be reduced].

Some Cardiologists have an average patient backlog of 3,000 patients [Chart will reduce]

Artificial Intelligence

The system leverages a powerful and proven artificial intelligence (AI) database to ensure accurate results.

Product Uses

Cardiologists
​HMOs
Family physicians
Hospitals
Clinics
Long-term care homes

Benefits, Efficiency & Savings

  • Detect up to 95% of all Common heart diseases, including Heart Failure, and all Heart Valve Diseases. Compare with ECG at only 44%.
  • Average # of days from primary care to cardiologist is 180 days vs. same day report
  • End-to-end cost savings for national health services.

Regulatory Compliance

The cardio device has received CE approval for sale in Europe.

Government agency/ministry pilots are underway in at least 5 countries in Europe, North America and Asia, and government use approvals are proceeding under emergency use conditions for the US FDA  and Health Canada. 

In an FDA-approved clinical study of more than 560 patients, "general practitioners using Cardio-1 increased their diagnostic effectiveness by more than 250% compared to their peers using the most advanced state-of-the-art ECG/EKG systems," reported a Director of Clinical Research in Europe.

Global Interest
​Europe CE & UK Approved

Europe & UK
​Germany
​Belgium
Spain
Italy
Denmark
Portugal
Ireland
​Northern Ireland
Latin America
Brazil 
​Mexico
Argentina
​​Chile
​Columbia
Other
​Turkey
India 
​ Pakistan
UAE
Nigeria
​Philippines
​India
India is one of the largest markets in the world.

"With the ever growing population in India, healthcare is always a challenge and India today faces a dual challenge of not just providing but providing it in an efficient way." said Dhruv Sachdev, IaS Partner New Delhi. "The Smart Device is the need of the hour and Cardio-1 is the perfect solution - with its state-of-the art AI and patient-friendly alternative to current solutions."
Philippines
​There are 70 million adults in the Phillipines.
​
"Heart disease is the #1 cause of death in the country. Diagnostic technology is often hard to reach geographically and even harder for average people to afford.  Cardio-1 will revolutionize healthcare and save many lives by breaking down these barriers to access."  Jayvi Aruta, VP TradePower  (www.tradepowerasia.com). 
Heart Facts UK
  • Heart and circulatory diseases cause a 25% of all deaths in UK, 160,000 deaths each year.
  • 7.6 million people living with a heart or circulatory disease.
  • Waiting list 3,000 patients per cardiologist.
Heart Facts Europe
Coronary Heart Disease Deaths in
  • France reached 62,000 or 14% of total deaths 
  • Finland reached 10,865 or 23.28% of total deaths. 
  • Netherlands reached 18,253 or 14.73% of total deaths.
  • Sweden reached 16,582 or 21.91% of total deaths.
  • Belgium reached 15,130 or 16.54% of total deaths
Heart Facts in Germany
  • ​Germany is one of the most affected in the world by heart disease.
  • Eighth in the world for highest rate of death attributed to heart disease. 
  • More than 310 people per year of every 100,000 die from heart disease in Germany - higher than the rates of both the United States and the UK.
Heart Facts in Ireland
  • Heart disease is the most common cause of death in Ireland.
  • 6,000 people have heart attacks in Ireland each year but many of these can be prevented.
  • Irish women are 7 times more likely to die from cardiovascular/heart disease than from breast cancer.
Heart Facts Northern Ireland
  • Heart and circulatory diseases cause 25% of all deaths in NI, or around 4,000 deaths each year, according to the British Heart Foundation (BHF),
Heart Facts Scotland
  • 685,000 people live with CVD; at least 48,000 of those have heart failure. 
  • CVD makes up a significant proportion of all long-term conditions. 
Heart Facts Spain
  • The  main cause of death in Spain in 2018 was ischaemic heart disease, which accounted for 14.6% of all deaths.
Heart Facts Belgium
​Coronary Heart Disease Deaths in Belgium reached 15,130 or 16.54% of total deaths (WHO 2018)

History

Since 2005, the company specialized in the development of AI-Powered technology for the earlier, non-invasive detection of heart diseases to helpprimary care physicians to enhance healthcare delivery by focusing on the patient diagnosis.


​"ECG technology is essentially unchanged over the past 100 years, and Cardio-1 is the first major step forward in its evolution."  Cardio Specialists are excited for these devices to help manage heart disease which is all to common." Cardio-1, CEO
IaS is a Global Platform that provides clients with strategic business opportunities and funds up to $250 million. 
Contact us about a Business Partnership with or Investment in Cardio-1
Ken Clarke, Partner
​IaS (Europe & Canada)
T: 001 4168382614

All the People & Tools You Need to Succeed !

Photos used under Creative Commons from wuestenigel wuestenigel